IMGN - ImmunoGen Inc. (IMGN) CEO Mark Enyedy on Q1 2020 Results - Earnings Call Transcript
ImmunoGen, Inc. (IMGN)
Q1 2020 Earnings Conference Call
May 01, 2020, 08:00 ET
Company Participants
Courtney O’Konek - Senior Director, Corporate Communications & IR
Mark Enyedy - President, CEO & Director
Anna Berkenblit - SVP & Chief Medical Officer
Conference Call Participants
John Newman - Canaccord Genuity
Earl DeSouza - H.C. Wainwright & Co.
Kennen MacKay - RBC Capital Markets
Tsan-Yu Hsieh - William Blair & Company
Biren Amin - Jefferies
David Ruch - SVB Leerink
Michael Schmidt - Guggenheim Securities
Jessica Fye - JPMorgan Chase & Co.
Presentation
Operator
Good morning, and welcome to